Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 32.08 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $613.845 million which beat the analyst consensus estimate of $610.869 million by 0.49 percent. This is a 2.47 percent decrease over sales of $629.400 million the same period last year.